Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maya Lipert

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Pharmaceutical Sciences|September 26, 2016
Mitigating Cocrystal Physical Stability Liabilities in Preclinical FormulationsSunny Bhardwaj, Maya Lipert, Annette Bak
Drug Discovery Today|June 25, 2023
Current screening, design, and delivery approaches to address low permeability of chemically synthesized modalities in drug discovery and early clinical developmentWenzhan Yang, Maya Lipert, Rebecca Nofsinger
AAPS Pharmscitech|January 4, 2020
Application and Impact of Human Dose Projection from Discovery to Early Drug DevelopmentDipal Patel, Wenzhan Yang, Maya Lipert, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Pharmaceutical Sciences|September 26, 2016
Mitigating Cocrystal Physical Stability Liabilities in Preclinical FormulationsSunny Bhardwaj, Maya Lipert, Annette Bak
Drug Discovery Today|June 25, 2023
Current screening, design, and delivery approaches to address low permeability of chemically synthesized modalities in drug discovery and early clinical developmentWenzhan Yang, Maya Lipert, Rebecca Nofsinger
AAPS Pharmscitech|January 4, 2020
Application and Impact of Human Dose Projection from Discovery to Early Drug DevelopmentDipal Patel, Wenzhan Yang, Maya Lipert, et al.
Pageof 1